Please assess the completion status of the following clinical trial:

Trial Title: Do You Need to Assess Myocardial Ischemia in Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients 55 to 75 years old had type-2 diabetes and at least two of the following cardiovascular risk factors:~  * urinary albumin excretion \> 30 mg/L or \> 30 mg/24 hours,~ * treated or untreated hypertension,~ * treated or untreated lipid abnormality,~ * peripheral arterial disease,~ * history of transient ischemic accident,~ * tobacco consumption~ * familial history of premature cardiovascular disease.~Exclusion Criteria:~* History of myocardial infarction, coronary artery disease, or stroke,~* Previous positive stress test or myocardial perfusion imaging,~* Negative stress test or myocardial perfusion imaging within the last three years

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Intervention (Type: EXPERIMENTAL): Patients are referred to a cardiologist for a systematic detection of silent ischemia by a bicycle exercise test performed according to the French Society of Cardiology protocol after washout of cardiovascular medications likely to interfere with the test. Dipyridamole Single Photon Emission Computed Tomography (SPECT) is used in patients unable to perform the exercise test, with a sub-maximal negative exercise test result or with electrocardiographic abnormalities impairing the interpretation of the exercise test. Subsequent investigations (such as coronary angiography) and treatments (such as revascularization procedures) are left at the cardiologist's decision.
- Control (Type: NO_INTERVENTION): Patients are treated according current guidelines but are not referred to a cardiologist

Based on this trial design, predict the completion outcome and termination type (if applicable).